← Back
Data updated: Mar 10, 2026
MONARCH PHARMS
Cardiovascular
MONARCH PHARMS is a major pharmaceutical company focused on Cardiovascular.
1955
Since
17
Drugs
-
Trials
5
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CORTISPORIN 2025-08-08
Labeling
CORTISPORIN 2025-08-08
Labeling
CORTISPORIN 2025-08-08
Labeling
SEPTRA 2025-02-21
Labeling
SEPTRA 2024-06-24
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (15)
Company Info
- First Approval
- 1955-07-27
- Latest
- 2025-08-08
- Applications
- 22